NEW YORK, May 28 -- Gene Logic of Gaithersburg, Md., said today Solvay Pharmaceuticals, a Brussels, Belgium-based firm, has purchased a subscription to the company's BioExpress system for drug target discovery research.
Financial details were not disclosed.
Gene Logic also said that Wyeth had renewed its subscription to the database of gene-expression information.